Clinical Trial Update: Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of pioglitazone on oxidative load, inflammatory endpoints, and vascular reactivity in obese non-diabetic patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University at Buffalo | Conditions: Inflammation | Phase 4 | Status: COMPLETED